New Study Links High Sugar Levels to Diabetic Eye Disease
Understanding Diabetic Retinopathy
A recent study has uncovered new mechanisms by which elevated sugar levels can damage vision, contributing to diabetic eye disease. These insights pave the way for potential treatment advancements for diabetic retinopathy, a serious condition that can lead to blindness. Diabetic retinopathy is closely associated with high blood glucose levels and often develops without noticeable symptoms, frequently necessitating surgical intervention.
Dr. Sayon Roy from the Department of Medicine and Ophthalmology at the Boston University School of Medicine emphasizes the severity of this condition, stating, “Diabetic retinopathy is the leading cause of blindness in the working-age population,” and highlights the absence of a definitive cure for this challenging eye condition.
The Role of Glucose and Cell Death
While the precise mechanisms by which elevated glucose levels lead to retinal cell death remain unclear, certain metabolites have been identified as contributors to cell death in various diseases. One such metabolite is Lysyl oxidase propeptide (LOX-PP), recognized as a toxin that can cause cell death in different tissues.
Research Findings on LOX-PP
In a study published in the American Journal of Pathology, researchers investigated the relationship between LOX-PP and glucose-induced retinal cell death. They assessed the impact of LOX-PP on blood vessels in the retinas of both healthy and diabetic rats. By administering synthetic LOX-PP directly into the eyes of these rats, they monitored for diabetic retinopathy-related pathologies such as swelling and blood vessel dysfunction.
The findings revealed that diabetic rats exhibited a higher prevalence of retinal vascular disorders compared to their healthy counterparts. Additionally, healthy rats that received LOX-PP displayed vascular malfunctions characteristic of diabetic retinopathy.
Subsequently, the researchers examined how high glucose levels influenced the growth and development of eye cells. They discovered that glucose elevation leads to increased levels of LOX-PP, which in turn promotes cell death in the retina.
Implications of the Study
Dr. Roy further elaborates in a press release: “We found that hyperglycemic and diabetic conditions increased LOX-PP levels. LOX-PP may induce cell death by compromising a cell survival pathway, and in retinas of diabetic rats, increased LOX-PP contributed to retinal vascular cell death associated with diabetic retinopathy. The administration of LOX-PP alone was enough to induce cell death.” This research highlights the novel role of LOX-PP in mediating cell death under high glucose conditions in retinal endothelial cells and in diabetic models.
The implications of this study are significant, marking the first time a direct connection has been established between high glucose levels and a toxic metabolite in the context of eye disorders. Future research is essential to clarify the specific role of LOX-PP in diabetes-related vascular abnormalities in the eye. Gaining a deeper understanding may facilitate drug development aimed at addressing these issues.
Reference
Kim, D., Lee, D., Trackman, P. C., Roy, S. Effects of High Glucose–Induced Lysyl Oxidase Propeptide on Retinal Endothelial Cell Survival Implications for Diabetic Retinopathy. Pathol, 2019.
Image by Jason Gillman from Pixabay.